Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

BACKGROUND: Recent studies indicate an increase in tumor progression and recurrence in head and neck squamous cell carcinomas (HNSCC) of cancer patients taking recombinant human erythropoietin (rhEpo) for anemia. This study was undertaken to investigate the potential role of rhEpo in invasion, proli...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Abhold, Eric, Rahimy, Elham, Wang-Rodriguez, Jessica, Blair, Katherine J, Yu, Michael A, Brumund, Kevin T, Weisman, Robert A, Ongkeko, Weg M
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3285115/
https://ncbi.nlm.nih.gov/pubmed/22188703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-553
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires